Researchers have expressed regarding the potential long-term neurocognitive effects of general anesthesia during the early stages of life. In view of this, our center has developed a program in which SA may be used as the sole agent for applicable surgical procedures. Spinal anesthesia (SA) has been used relatively sparingly in the pediatric population, as it is typically reserved for patients in whom the perceived risk of general anesthesia is high due to comorbid conditions.
All news from Anaesthesiology
A new study that demonstrates the drug-related morbidities(MRM), factors and causes detected in patients seeking the emergency service of a university hospital in southern Brazil. There are risk factors and causes detected in patients who seek the Hospital Emergency Service of a University in the South of Brazil. Data collection was based on the application of a questionnaire to patients of a minimum age of 18 years, that signing the Term of Free and Informed Consent (TFIC), during the period from October 2013 to March 2014, and analysis of electronic record charts.
Researchers pieced together traces of Homo naledi's brain shape from an extraordinary collection of skull fragments and partial crania, from at least five adult individuals. One of these bore a very clear imprint of the convolutions on the surface of the brain's left frontal lobe. The recently-discovered species Homo naledi may have had a pint-sized brain, but that brain packed a big punch. A new study by researchers that include the imprints of the brain upon the skulls of this species, called endocasts. The study was published in the Proceedings of the National Academy of Sciences.
A study is to determine the relationship between the expression level and biological role of LRRK2 in CRS. Chronic rhinosinusitis (CRS), commonly divided into CRS with nasal polyps (CRSwNP) and without nasal polyps (CRSsNP) is an inflammatory disease which mechanism remains unclear. Leucine-rich repeat kinase 2 (LRRK2) has been proved to be a negative regulator of inflammation response while its role in the pathogenesis of CRS has yet to be revealed.
The FDA announced approval on May 17 of a novel preventive treatment for migraine headaches. Aimovig is the first in a new class of migraine-specific drugs that works by blocking an action of a protein that is increased in people with a migraine during headache attacks.
Heart doctors from the European Society of Cardiology (ESC) Council on Stroke are calling on national health authorities for permission to provide stroke patients with mechanical thrombectomy, a life-saving treatment for acute ischaemic stroke, in regions where there is a lack of trained specialists. Details of the proposal are presented today at EuroPCR 2018.
Using a procalcitonin assay does not reduce antibiotic use among patients with a suspected lower respiratory tract infection, doctors behind a large randomized study done at 14 U.S. hospitals have concluded.
Researchers of the laboratory "Medical ultrasound equipment" of Peter the Great St. Petersburg Polytechnic University (SPbPU) developed a high-tech device-transformer for ultrasound examination, named "Ultrasound mobile". The new equipment is the combination of three modifications in one device.
For patients with very severe acute respiratory distress syndrome (ARDS), 60-day mortality is not significantly lower with venovenous extracorporeal membrane oxygenation (ECMO) than with continued conventional treatment, according to a study published online in the issue of the New England Journal of Medicine.
People’s experiences of death, dying and bereavement are only partially determined by formal health and social care services. A broad-based alliance of organizations and individuals was established in Scotland in 2011 with the aim of influencing a wider range of social, cultural and other environmental factors which impact on people’s experiences towards the end of life. A small central resource hosted by the Scottish Partnership for Palliative Care (SPPC) provides infrastructure, resources, promotion, events, and advocacy for the alliance.
Novoheart (“Novoheart” or the “Company”) today announced that the next generation of its ‘Human heart-in-a-jar’ technology – which makes up a key component of its comprehensive MyHeartTM Platform – will be unveiled for the first time at the Annual Meeting of the International Society for Stem Cell Research (ISSCR), held in Melbourne, Australia from 20-23 June 2018.
The management of uncomplicated herpes zoster involves antiviral therapy to promote faster healing of cutaneous lesions and, in patients with moderate to severe acute neuritis, analgesic treatment may be associated.